SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001711279-22-000018
Filing Date
2022-05-09
Accepted
2022-05-09 16:19:43
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krys-20220509.htm   iXBRL 8-K 39673
2 EX-99.1 exhibit991may92022.htm EX-99.1 50820
6 image_0.jpg GRAPHIC 12969
  Complete submission text file 0001711279-22-000018.txt   243837

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20220509.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20220509_lab.xml EX-101.LAB 22164
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20220509_pre.xml EX-101.PRE 11598
8 EXTRACTED XBRL INSTANCE DOCUMENT krys-20220509_htm.xml XML 10362
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 22905293
SIC: 2836 Biological Products, (No Diagnostic Substances)